James Renwick McCullough - 01 Jul 2023 Form 3 Insider Report for Renalytix plc (RNLX)

Role
Chief Executive Officer, Director
Signature
/s/ Katie Kazem, Attorney-in-Fact
Issuer symbol
RNLX
Transactions as of
01 Jul 2023
Net transactions value
$0
Form type
3
Filing time
03 Jul 2023, 16:21:56 UTC
Next filing
07 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RNLX Ordinary Shares 191,988 01 Jul 2023 Direct F1
holding RNLX Ordinary Shares 2,554,398 01 Jul 2023 By The McCullough 2020 Irrevocable Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each representing two Ordinary Shares.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney